ASH awards support resumption of hematologic research paused by pandemic
Click Here to Manage Email Alerts
ASH awarded funding to 19 early-career investigators to support resumption of research paused due to the COVID-19 pandemic.
The newly created ASH Research Restart Award program — open to applicants worldwide — will award up to $50,000 to each recipient to support their high-impact hematologic research.
The funding is designed to support 1 year of research, including salaries, supplies, training, research expenses and publication fees.
“The ASH Research Restart Award offers a necessary lifeline for promising biomedical researchers facing unprecedented disruption due to COVID-19 that has led to impaired productivity, lost momentum and uncertain professional futures,” ASH President Martin S. Tallman, MD, of Memorial Sloan Kettering Cancer Center, said in a society-issued press release. “At this time when the pandemic has underscored the vital importance of science and public health, ASH remains committed to supporting researchers as they work to advance both.”
The recipients are: Frederick Allen, PhD, of University of Pennsylvania School of Veterinary Medicine; Theodore Braun, MD, PhD, of Oregon Health & Science University; Sisi Chen, PhD, of Memorial Sloan Kettering Cancer Center; Nirav Dhanesha, PhD, of University of Iowa; Sarah Ducamp, PhD, of Boston Children’s Hospital; Patrick Ellsworth, MD, of University of North Carolina; Md Kamrul Hasan, PhD, of University of California, San Diego; Christian Hurtz, PhD, of University of Pennsylvania; Thomas Koehnke, MD, of Stanford University School of Medicine; Prerna Malaney, PhD, of The University of Texas MD Anderson Cancer Center; Maria Maryanovich, PhD, of Albert Einstein College of Medicine; Coraline Mlynarczyk, PhD, of Weill Cornell Medicine; Danitza Nebor, PhD, of Baylor College of Medicine; Simone Riedel, PhD, of Children's Hospital of Philadelphia; Maria Guillamot Ruano, PhD, PharmD, of NYU Langone Medical Center; Christian Schürch, MD, PhD, of University of Tübingen in Germany; Claudio Scuoppo, PhD, of Columbia University Irving Medical Center; Natthakan Thongon, PhD, of The University of Texas MD Anderson Cancer Center; and Matthew Witkowski, PhD, of New York University School of Medicine.
Click Here to Manage Email Alerts